Drug Store News1h
FDA approves new indication for Novo Nordisk’s Ozempic
Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...
Hosted on MSN3h
Great British Bake Off's Prue Leith says weight loss jabs like Ozempic 'take the joy out of life' as she calls for schools to teach children how to cook healthy meals
The Great British Bake Off judge said the injections 'take the joy out ... It's easy to do,' she said. Ozempic, and its sister drug Wegovy, have the same active ingredient semaglutide. They work by ...
Pros and cons of weight-loss jabs
Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...
Weight loss pill could replace injections, would be transformative for millions
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Investor's Business Daily on MSN19h
Novo Surges As Ozempic Drives Fourth-Quarter Beat. But Supply Shortages Expected.
Novo Nordisk stock reversed a three-day downtrend Wednesday after the weight-loss drugs kingpin leaned on Ozempic for a fourth-quarter beat.
Why Novo Nordisk Stock Is Soaring Today
Detailed price information for Compass Inc Cl A (COMP-N) from The Globe and Mail including charting and trades.
infectiousdiseaseadvisor.com21h
Ozempic Approval Expanded to Include T2D Patients With Chronic Kidney Disease
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
Novo Nordisk's Innovation Supports a Wide Moat and GLP-1 Market Growth
We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...